Systochem Formulations Private Limited
About Systochem Formulations Private Limited
Data last updated:
Systochem Formulations Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 April 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1999PTC099214.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.02 Lakh. It is led by directors Sukh Dev Garg and Shrawan Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1719/39 Mangal Building No. – 2 Bhagirath Place, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.95 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹83,815 (net margin 28.4%) and EBITDA of ₹1.13 Lakh (EBITDA margin 38.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 7% over five years.
The company has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2 Lakh; the latest was in March 2018.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Systochem Formulations Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address1719/39 Mangal Building No. – 2 Bhagirath Place, Delhi, India – 110006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Systochem Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Systochem Formulations is financial and insurance service. In detail, this covers other financial activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Systochem Formulations Private Limited, buy the company report.
Financials of Systochem Formulations Private Limited
FY 2025 filings availableSystochem Formulations Private Limited reported revenue of ₹2.95 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 10% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹83,815 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 38.4% | ||||
| Net Profit Margin | 28.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Systochem Formulations Private Limited, buy the company report.
Board of directors of Systochem Formulations Private Limited
Systochem Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sukh Dev Garg Also directs: Systochem Laboratories Limited | Director | 08 Apr 1999 | 27 Years 7 Months | Current |
| Shrawan Singla | Director | 08 Apr 1999 | 27 Years 7 Months | Current |
Auditor
Systochem Formulations Private Limited is audited by SUNIL SINGLA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUNIL SINGLA & CO | FY 2020 | 009782N |
Shareholding
The shareholding of Systochem Formulations Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Systochem Formulations Private Limited, buy the company report.
Deals & funding
Systochem Formulations Private Limited has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2 Lakh; the latest was in March 2018.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2017 | Funding round | ₹2 Lakh | Investors: an individual |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Systochem Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Systochem Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Systochem Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Systochem Formulations Private Limited has 2 board changes on record since 1999: 2 appointments. The latest: Shrawan Singla was appointed as Director on 08 Apr 1999.
Frequently asked questions
Systochem Formulations is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 April 1999 (27+ years old) and is registered under CIN U24239DL1999PTC099214.
Systochem Formulations has 2 current directors:
- Sukh Dev Garg - Director
- Shrawan Singla - Director
The latest financial statements of Systochem Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Systochem Formulations is U24239DL1999PTC099214. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Systochem Formulations was incorporated on 08 April 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.
Systochem Formulations has 3 deals on record (2 secondary share transfers, 1 funding round), with disclosed funding of ₹2 Lakh; the latest was in March 2018.
Shrawan Singla was appointed as Director on 08 Apr 1999. Sukh Dev Garg was appointed as Director on 08 Apr 1999.
The registered office of Systochem Formulations is at 171939 Mangal Building No. – 2 Bhagirath Place, Delhi, India – 110006.
Systochem Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Systochem Formulations is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
